Evidence map›Paper›PMID 42106477›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2026

Sex-specific role of microglia in Δ

Ana Maria Raymundi, Nathalie Carla Cardoso, Gabriel Costa Lourenço, Ruliam Queiroz, Maressa D Dolzan, Luciano Vitali, Erika Meyer, Sabrina Francesca Lisboa, Francisco Silveira Guimarães, Graziano Pinna and 2 more

Abstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ana Maria RaymundiDepartment of Pharmacology, Federal University of Paraná, Curitiba, PR, Brazil.ORCID http://orcid.org/0000-0002-8012-4104
Nathalie Carla CardosoDepartment of Pharmacology, Federal University of Paraná, Curitiba, PR, Brazil.
Gabriel Costa LourençoDepartment of Pharmacology, Federal University of Paraná, Curitiba, PR, Brazil.ORCID http://orcid.org/0009-0009-6465-6707
Ruliam QueirozDepartment of Pharmacology, Federal University of Paraná, Curitiba, PR, Brazil.
Maressa D DolzanFederal Institute of Santa Catarina, Itajaí, SC, Brazil.
Luciano VitaliDepartment of Chemistry, Federal University of Santa Catarina, Florianópolis, SC, Brazil.
Erika MeyerDepartment of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.ORCID http://orcid.org/0000-0002-8425-6358
Sabrina Francesca LisboaDepartment of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.ORCID http://orcid.org/0000-0002-2069-3524
Francisco Silveira GuimarãesDepartment of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.ORCID http://orcid.org/0000-0003-4092-7778
Graziano PinnaThe Psychiatric Institute, Department of Psychiatry, College of Medicine, University of Illinois Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0001-7541-4855
Leandro José BertoglioDepartment of Pharmacology, Federal University of Santa Catarina, Florianópolis, SC, Brazil.ORCID http://orcid.org/0000-0003-2876-1146
Cristina Aparecida Jark SternDepartment of Pharmacology, Federal University of Paraná, Curitiba, PR, Brazil. cristina.stern@ufpr.br.ORCID http://orcid.org/0000-0002-1736-5503

Funding

Alcohol-induced epigenetic reprogramming of PPAR-α affects allopregnanolone biosynthesisR01AA030292 · NIAAA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GRAZIANO PINNA · 2023 to 2026
$1.4M
Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Científico e Tecnológico (National Council for Scientific and Technological Development) 304851/2022-1Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Científico e Tecnológico (National Council for Scientific and Technological Development) 309111/2022-6NIAAA NIH HHS R01 AA030292U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01AA030292
6 · The paper itself

Abstract

In PTSD, microglia are more engaged in fear-related circuits, where they participate in fear memory processing responses. The reconsolidation-impairing effect of Δ⁹-tetrahydrocannabinol (THC), the primary psychoactive constituent of Cannabis, is typically linked to cannabinoid type-1 receptor (CB1) signaling. THC also engages peroxisome proliferator-activated receptor gamma (PPARγ), and both CB1 and PPARγ modulate neuroimmune processes, including microglial activity. This dual mechanism suggests that THC's impact on fear memory reconsolidation may extend beyond classical cannabinoid signaling. We hypothesize that THC disrupts contextual fear memory reconsolidation via microglial recruitment in the dorsal hippocampus (DH) through a sex-specific engagement of CB1 and PPARγ. Adult male and female Wistar rats underwent contextual fear conditioning, followed by THC (0.002 mg/kg, i.p.) or vehicle administration immediately after memory retrieval. Microglial involvement was assessed using immunofluorescence and pharmacological and chemogenetic inhibition in DH. The role of CB1 and PPARγ receptors was assessed via intra-DH selective antagonist infusion. THC impaired reconsolidation in males and females. In males, fear memory retrieval increased microglial engagement in the DH CA1 subfield, which THC further enhanced. Pharmacological and chemogenetic inhibition of microglia, as well as selective CB1 and PPARγ antagonism, blocked THC's effects in males. In females, THC-induced reconsolidation blockade was cycle-dependent, occurring at estrus and diestrus but not at proestrus, and was mediated exclusively through CB1 activation. These findings identified sex-specific neuroimmune pathways mediating THC's reconsolidation impairment, offering a mechanistic basis for novel sex-tailored therapeutic opportunities.

Indexed as

DronabinolFearMemoryMemory ConsolidationMicrogliaSex CharacteristicsAnimalsConditioning, PsychologicalFemaleHippocampusMalePPAR gammaRatsRats, WistarReceptor, Cannabinoid, CB1DronabinolPPAR gammaReceptor, Cannabinoid, CB1

Identifiers

PMID42106477
PMCPMC13598131

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.